| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $133.7M | — | +13.1% |
| Cost of Revenue | $31.8M | — | +14.7% |
| Gross Profit | $101.9M | — | +12.6% |
| R&D Expense | $26.1M | — | +9.4% |
| SG&A Expense | $20.2M | — | -15.3% |
| Operating Income | $12.5M | — | +582.9% |
| Pre-tax Income | $4.2M | — | +208.4% |
| Income Tax | $4.8M | — | +45.5% |
| Net Income | -$615K | — | +91.4% |
| EPS (Basic) | $0.00 | — | +100.0% |
| EPS (Diluted) | $0.00 | — | +100.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $117.8M | +5.3% | +25.2% |
| Accounts Receivable | $46.1M | -8.5% | +3.3% |
| Current Assets | $211.0M | -2.5% | +14.8% |
| Total Assets | $1.40B | -1.0% | +3.2% |
| Current Liabilities | $167.4M | -7.9% | +8.9% |
| Long-term Debt | $393.1M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $17.5M | — | -11.2% |
| Capital Expenditures | $1.7M | — | -48.7% |
| Investing Cash Flow | -$4.2M | — | +30.2% |
| Financing Cash Flow | -$4.4M | — | +39.3% |
| Free Cash Flow | $15.8M | — | -3.7% |
| +18.2% |
| Total Liabilities | $596.5M | -1.4% | +3.4% |
| Stockholders' Equity | $798.8M | -0.7% | +3.1% |